SG Americas Securities
IGMS

SG Americas Securities’s IGM Biosciences IGMS Stock Holding History

SG Americas Securities’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,304
Closed -$17K – 3464
2025
Q2 		$17K Buy
+15,304
New +$18.7K ﹤0.01% 2835
2022
Q4 		– Sell
-6,322
Closed -$144K – 3198
2022
Q3 		$144K Buy
+6,322
New +$128K ﹤0.01% 2576
2021
Q4 		– Sell
-6,279
Closed -$413K – 3583
2021
Q3 		$413K Buy
6,279
+4,990
+387% +$382K ﹤0.01% 2677
2021
Q2 		$107K Sell
1,289
-983
-43% -$72.8K ﹤0.01% 2630
2021
Q1 		$174K Sell
2,272
-15,156
-87% -$1.38M ﹤0.01% 2764
2020
Q4 		$1.54M Sell
17,428
-19,258
-52% -$1.35M 0.01% 1254
2020
Q3 		$2.71M Buy
36,686
+19,724
+116% +$1.17M 0.02% 582
2020
Q2 		$1.24M Buy
16,962
+15,082
+802% +$916K 0.01% 1201
2020
Q1 		$106K Buy
+1,880
New +$82.4K ﹤0.01% 2964

Other funds holding IGMS

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

SG Americas Securities's IGMS Position: Q3 2025 in Review

SG Americas Securities sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 15,304 shares — an estimated $17K sold.

SG Americas Securities first reported a position in IGMS in Q1 2020 and held it in 9 quarters. The position peaked at $2.71M in Q3 2020. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.

  • SG Americas Securities reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
  • SG Americas Securities sold 15,304 IGM Biosciences shares in Q3 2025, an estimated $17K.
  • SG Americas Securities first reported a position in IGM Biosciences in Q1 2020 and held it in 9 quarters.
  • SG Americas Securities's IGM Biosciences position peaked at $2.71M in Q3 2020.
  • 1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.

Based on SG Americas Securities's 13F filing for Q3 2025, filed 23 Oct 2025.